Clinical trial
Prospective Study for Symptomatic Relief of ET With Cala Therapy
NCT03597100 · Cala Health, Inc., Industry · Completed
Key facts
| NCT number | NCT03597100 |
|---|---|
| Title | Prospective Study for Symptomatic Relief of ET With Cala Therapy |
| Official title | Prospective Study for Symptomatic Relief of Essential Tremor With Cala Therapy |
| Acronym | PROSPECT |
| Lead sponsor | Cala Health, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Essential Tremor |
| Intervention type | Device |
| Interventions | Cala TWO |
| Enrollment | 263 |
| Start date | Dec 14, 2018 |
| Primary completion | May 29, 2019 |
| Completion | May 29, 2019 |
| First posted | Jul 24, 2018 |
| Last update posted | Oct 12, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: